fbpx
A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

Benefits of Stabilized Stannous Fluoride

Offering antimicrobial and cariostatic properties, a new generation of therapeutics containing stabilized stannous fluoride can help improve oral health on multiple levels.

0

Despite modern medical advances, oral diseases, such as caries and periodontitis, continue to negatively impact worldwide health. In fact, dental diseases affect almost 3.5 billion people around the globe,1 with caries a leading cause of oral health conditions. Fluoride is the gold standard in caries prevention and offers myriad oral health benefits. While stannous fluoride has long been established as an anticaries agent, its inclusion in oral health products has a challenging history due to problems with effectively stabilizing this agent.2,3 With advances in technology, these issues have been resolved, and oral health products containing stannous fluoride can now be recommended to patients who may benefit from their anticaries and antimicrobial properties. 

In addition to caries-prevention effects, stannous fluoride, as noted, is an antimicrobial agent that provides dual therapeutic benefits to patients who are at risk for caries and periodontal disease.1,2,4–6 Despite its proven clinical efficacy, early versions of stannous fluoride dentifrice failed due to poor stabilization or incompatibility with other ingredients, such as abrasives.1–3 White3 defines stability as the “capacity of a formula [after processing and during storage] to maintain levels of available and bioavailable agent sufficient to deliver desired therapeutic action.” Over the past decade, scientists have been able to successfully stabilize stannous fluoride.2 Currently, stannous fluoride is available as a prescription gel, over-the-counter (OTC) mouthrinse, and OTC dentifrice. This article will focus on the beneficial properties of stannous fluoride dentifrices, as clinicians may wish to recommend these products for daily oral care. 

In 1950, Fluoristan made its debut as the first stannous fluoride dentifrice (Figure 1). In 1964, Fluoristan earned the American Dental Association’s Seal of Acceptance. However, due to poor stability, the stannous fluoride was later replaced with sodium fluoride and sodium monofluorophosphate. In the 1970s, sodium fluorides with greater anticaries effect were launched. In 1997, reformulated versions of stannous fluoride toothpaste were introduced. However, a portion of the population still experienced staining from these formulations. Over the past decade, scientists have successfully stabilized stannous fluoride,1–3,7–9 making stannous fluoride-containing toothpastes a viable option for daily self-care.

FIGURE 1. History of stannous fluoride use.
FIGURE 1. History of stannous fluoride use.

STABILIZATION PROCESS

Stannous is tin fluoride. A stannous fluoride dentifrice contains 0.454% stannous. The therapeutic efficacy of stannous fluoride depends on stabilization, which requires sustaining oxidation of the tin. When free stannous ions are oxidized, they become stannic ions and are no longer effective. In addition, stannous fluoride is water soluble; it will dissociate in water to form fluoride ions and tin hydroxide, a process known as hydrolysis. All of these chemical changes affect the bioavailability of stannous and result in deactivation of this essential ingredient, subsequently causing stannous fluoride to lose its therapeutic value.2,3,5 

There have been a number of attempts to overcome this, including: 

  • The removal of water
  • Addition of stannous chloride (salt), which serves to replenish the stannous reservoir 
  • Incorporation of polyphosphates and silicas, which reduce staining
  • Inclusion of other chemicals, such as chelating agents 

Chelation is the process used to reduce or remove heavy metals, which is implemented to prevent hydrolysis. While these formulations have been successful in stabilizing stannous fluoride, several shortcomings were evident, such as poor viscosity, grittiness, increased potential for extrinsic staining, metallic taste, and a weak flavor. From a patient’s perspective, tooth staining is the most significant drawback.2,9–11 

Recently, several dentifrice manufacturers have successfully stabilized stannous fluoride. The addition of zinc phosphate, zinc citrate or vegetable glycerin, along with other ingredients, has created a stabilizing effect.1–3 These newer formulations maintain the clinical efficacy of stannous fluoride without compromising the flavor, texture or esthetics. 

BENEFITS OF STANNOUS FLUORIDE

Fluorides used in dentifrices include sodium fluoride, sodium monofluorophosphate and stannous fluoride. All of these agents offer anticaries benefits. In addition, stannous fluoride provides bacteriostatic and bactericidal properties, enabling it to fight plaque and gingivitis.10,12,13 The U.S. Food and Drug Administration has approved stannous fluoride for antigingivitis and anticaries effects in the oral care monograph.4 In addition, stannous fluoride deposits a precipitate or protective mineral barrier, known as a smear layer, that is acid resistant. This smear layer obstructs the dentinal tubules, providing anti-sensitivity and anti-erosive mechanisms of action.12,14

PATHOGENIC BIOFILM REDUCTION

As an organized matrix of diverse microbes adhering to one another, as well as to structures in the oral cavity, pathogenic biofilm must be disrupted through mechanical and/or chemical means to prevent the development of caries lesions and periodontal conditions. Mechanical disruption of the biofilm is ideal, but complete removal during self-care is not always possible. Stannous fluoride has been shown to reduce biofilm burden, with the primary action being its retention on plaque.4–6,11,15 In addition, stannous fluoride interferes with the metabolic function of planktonic bacteria, as well as aerobic and anaerobic biofilm, thereby affecting its ability to adhere to structures in the oral cavity.2 

ANTIMICROBIAL EFFECTS

The stannous ion, specifically, the solubility of tin, has a broad-spectrum effect by interfering with the metabolic function of oral bacteria and inhibiting bacterial adhesion.2,4–6 Stannous fluoride restricts the bacterial uptake of sugars, interfering with the pathogen’s nutritional source. Further, stannous binds to the bacterial cells, preventing an inflammatory response. The antimicrobial properties of stannous fluoride also offer a high level of substantivity;5 meaning, the stannous ion remains at levels high enough to inhibit bacterial metabolic activity for up to 12 hours after use.16 

CALCULUS REDUCTION

Calculus forms due to mineralized plaque; these accretions have a rough surface and serve as a reservoir for pathogenic bacteria, which can cause periodontal disease. Stannous fluoride has been shown to reduce plaque/biofilm adhesion and may support the reduction of calculus accumulation. Furthermore, some dentifrice manufacturers have incorporated additional anticalculus ingredients, such as sodium hexametaphosphate, pyrophosphate and/or zinc. These agents have been shown to interfere with the crystal formation of calculus, weakening its structure.17,18

DENTINAL HYPERSENSITIVITY

Dentinal hypersensitivity is a common clinical complaint, and these sensitivities arise from open dentinal tubules that occur from gingival recession and/or enamel erosion. Treating dentinal hypersensitivity can be accomplished through in-office procedures or the use of OTC products. The first means of addressing sensitivity includes sealing the dentinal tubules to reduce the dentin’s permeability to stimuli. The second approach is desensitizing nerve endings to disrupt pain transmission to the brain, which can be accomplished with potassium nitrate, which depolarizes the nerve endings. Many OTC products are designed to occlude the dentinal tubules. Stannous fluoride dentifrices, for example, provide relief from sensitivity by forming a precipitate or smear layer of an insoluble metal compound that inherently occludes dentinal tubules.14 

Children and adults who frequently consume highly acidic beverages, such as sports drinks, fruit juices and soft drinks, may experience enamel erosion. As this condition is irreversible, prevention is key. Stannous fluoride provides a protective layer rich in calcium and phosphate, which may be able to withstand acid challenges. Research suggests the protective layer provided by stannous fluoride produces resistance to acid erosion.12 

CARIES REDUCTION

Stabilized stannous fluoride allows 90% fluoride uptake, significantly increasing the available amount of soluble fluoride. While fluoride in general provides the greatest benefit on smooth surfaces of enamel, some research suggests stannous fluoride may also provide a reduction in root caries.3,8 

CONCLUSION

Oral health professionals have many options available to suggest for patients’ self-care regimens. Thanks to advances that have allowed more effective stabilized stannous fluoride formulas, dentifrices containing this agent offer many beneficial properties, including anticaries, antimicrobial, antiplaque and anti-hypersensitivity effects. In addition, newer formulations of stannous fluoride dentifrice have improved taste, esthetics and consistency, which help encourage patient compliance. Given the importance of fluoride exposure in preventing caries and periodontal disease, stannous fluoride products are worth considering when issuing patient recommendations. 


Key Takeaways

  • Although stannous fluoride’s anticaries properties have long been established, its inclusion in oral health products has a challenging history due to problems with stabilizing this agent.2,3
  • Technological advances have helped resolve these issues, as the addition of zinc phosphate, zinc citrate or vegetable glycerin, along with other ingredients, has had a stabilizing effect.1–3
  • These new-generation formulas maintain clinical efficacy without compromising the flavor, texture or esthetics of stannous fluoride-containing therapeutics.
  • Currently, stannous fluoride is available as a prescription gel, over-the-counter (OTC) mouthrinse, and OTC dentifrice.
  • Together with its cariostatic properties, this agent’s antimicrobial action provides a dual therapeutic benefit to patients who are at risk for caries and periodontal disease.1,2,4–6
  • In fact, the U.S. Food and Drug Administration has approved stannous fluoride for antigingivitis and anticaries effects in the oral care monograph.4
  • In addition, stannous fluoride deposits a precipitate that obstructs dentinal tubules, providing anti-sensitivity and anti-erosive protection.12,14
  • In light of these developments, stannous fluoride can now be recommended to patients who may benefit from its anticaries and antimicrobial properties.

REFERENCES

  1. Ciancio SG. Whole mouth health. J Am Dent Assoc. 2019;150(Suppl 4):S1–S4.
  2. Meyers CP, Pappas I, Makwana E, et al. Solving the problem with stannous fluoride: Formulation, stabilization, and antimicrobial action. J Am Dent Assoc. 2019;150(Suppl 4):S5–S13.
  3. White DJ. A “return” to stannous fluoride dentifrices. J Clin Dent. 1995;6(Spec No):29–36.
  4. Haraszthy VI, Raylae CC, Sreenivasan PK. Antimicrobial effects of a stannous fluoride toothpaste in distinct oral microenvironments. J Am Dent Assoc. 2019;150(Suppl 4):S14–S24. 
  5. Seriwatanachai D, Triratana T, Kraivaphan P, et al. Effect of stannous fluoride and zinc phosphate dentifrice on dental plaque and gingivitis: a randomized clinical trial with 6-month follow-up. J Am Dent Assoc. 2019;150(Suppl 4):S25–S31.
  6. Salzer S, Slot DE, Dorfer CE, Van der Weijden GA. Comparison of triclosan and stannous fluoride dentifrices on parameters of gingival inflammation and plaque scores: a systematic review and meta-analysis. Int J Dent Hyg. 2015;13:1–17. 
  7. He T, Farrel S. The case for stabilized stannous fluoride dentifrice: an advanced formulation designed for patient preference. J Clin Dent. 2017;28(Spec Iss B):B1–B5.
  8. Stookey GK, Mau MS, Isaacs RL, Gonzalez-Gierbolinib C, Bartizekc RD, Biesbrock AR. The relative anticaries effectiveness of three fluoride-containing dentifrices in Puerto Rico. Caries Res. 2004;38:542–550.
  9. Li Y, Suprono M, Mateo LR, Zhang YP, et al. Solving the problem with stannous fluoride: Extrinsic stain. J Am Dent Assoc. 2019;150(Suppl 4):S38–S46. 
  10. Hu D, Li X, Liu H, et al. Evaluation of a stabilized stannous fluoride dentifrice on dental plaque and gingivitis in a randomized controlled trial with 6-month follow-up. J Am Dent Assoc. 2019;150(Suppl 4):S32–S37.
  11. Biesbrock A, He T, DiGennaro J, Zou Y, Ramsey D, Garcia-Godoy F. The effects of bioavailable gluconate chelated stannous fluoride dentifrice on gingival beelng: Meta-analysis of eighteen randomized controlled trials. J Clin Periodontol. 2019;46:1205–1216. 
  12. West NX, Seong J, Hellin N, Eyon H, Barker ML, He T. A clinical study to measure anti-erosion properties of a stabilized stannous fluoride dentifrice relative to a sodium fluoride/triclosan dentifrice. Int J Dent Hyg. 2017;15:113–119. 
  13. Baig A, He T. A novel dentifrice technology for advanced oral health protection: a review of technical and clinical data. Compend Contin Educ Dent. 2005;26(Suppl 1):4–11.
  14. Hines D, Xu S, Stranick M, et al. Effect of a stannous fluoride toothpaste on dentinal hypersensitivity. J Am Dent Assoc. 2019;150(Suppl 4):S47–S59.
  15. Gerlach RW, Sagel, PA. Initial evidence of two-step dentifrice/gel sequence effects on health: outcomes from three randomized controlled trials. Am J Dent. 2018;31(Spec Iss A):7A–12A. 
  16. Ramji N, Baig A, He T, et al. Sustained antibacterial actions of a new stabilized stannous fluoride dentifrice containing sodium hexametaphosphate. Compend Contin Educ Dent. 2005;26(9 Suppl 1):19–28. 
  17. He T, Anastasia MK, Zsiska M, Farmer T, Schneiderman E, Milleman JL. In vitro and in vivo evaluations of the anticalculus effect of a novel stabilized stannous fluoride dentifrice. J Clin Dent. 2017;28:B21–B26.
  18. Schiff T, Saletta L, Baker RA, et al. Anticalculus efficacy and safety of a stabilized stannous fluoride dentifrice with hexametaphosphate. Compend Contin Educ Dent. 2005;26(9 Suppl 1):29–34.

From Decisions in Dentistry. May 2022;8(5)8, 10, 13.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

BLACK FRIDAY / CYBER MONDAY
CE PROMOTION

Coupon has expired

Stay top of your profession with our evidence-based peer-reviewed continuing education courses written by world-class educators and researchers!

Get Black Friday CE Savings!